OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2017
(1)
Release Date
2023
(4)
2022
(2)
2025
(1)
Lab affiliation
Proteomics Unit Spanish National Cancer Research Center (CNIO) Madrid (Spain)
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Proteomics of Secretomes and Exosomes in Melanoma
Exosomes were purified from several cell lines with different metastatic potential. Seecreted proteins were isolated from the same samples using the approach from Eichelbaum et al. Nat Biotechnol 2012
ORGANISM(S):
Homo sapiens (Human)
2017-06-29
|
PXD002703
|
Pride
Melanoma
Proteomics
Secretomes
Metastasis
Exosomes
Cite
Treatable traits in the NOVELTY study.
Not available
S-EPMC9795904
|
biostudies-literature
Cite
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
Not available
S-EPMC10082977
|
biostudies-literature
Cite
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY.
Not available
S-EPMC10274410
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets